Huntington Ingalls Industries Inc vs Tilray Brands Inc — how do they compare? Huntington Ingalls Industries Inc trades at $322.88 (market cap $12.88B), while Tilray Brands Inc trades at $4.72 (market cap $638.11M). The key difference: Huntington Ingalls Industries Inc is far larger — about 20.2× Tilray Brands Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.69% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| HII | TLRY | |
|---|---|---|
Market Cap | $12.88B | $638.11M |
Sector | Technology | Health |
52-Week High | $453.73 | $21.00 |
52-Week Low | $265.40 | $3.88 |
Enterprise Value | $15.80B | $805.25M |
Dividend Yield | 1.69% | — |
Signals from Pluang's Aura AI — not financial advice
HII trades at $326.80, down 1.21% over the past day, with a bullish technical outlook supported by moving averages and key support at $326. The company reported strong Q2 2026 earnings of $5.27 EPS, beating estimates, with revenue growth of 10.9% year-over-year. Recent contract awards, including a $2.2 billion task order for surveillance and intelligence capabilities, highlight ongoing government demand. Valuation metrics show a P/E of 19.53 and P/S of 0.98, indicating reasonable pricing relative to earnings and sales.
The investment outlook is positive, driven by robust defense contracts and operational improvements, with a consensus price target of $359.67 suggesting 10% upside. Risks include dependence on U.S. military spending and potential political headwinds affecting naval budgets. Analyst sentiment is mixed but leans bullish, with 44% buy ratings. Overall, HII presents a solid opportunity in the defense sector, though investors should monitor contract execution and macroeconomic factors.
TLRY trades at $4.68, up 5.88% today, amid bullish technical signals and news-driven momentum. The company reported record fiscal 2026 revenue of $915 million but posted a net loss of $121 million, with profitability challenges persisting. Recent developments include new product launches and partnerships, while analyst sentiment remains mixed with a majority hold rating.
Outlook hinges on revenue growth and margin improvement, but risks include sustained losses, high debt, and competitive pressures. The stock offers speculative appeal if execution improves, yet volatility and dilution concerns warrant caution for investors.
Trailing returns across standard periods
Latest headlines on both assets
Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →